T1	Age 2 13	67-year-old
T2	Sex 14 19	woman
T3	Clinical_event 24 28	sent
E1	Clinical_event:T3 
T4	Nonbiological_location 32 52	emergency department
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Sign_symptom 64 69	fever
E2	Sign_symptom:T5 
T6	Sign_symptom 74 78	sore
E3	Sign_symptom:T6 
T7	Biological_structure 79 85	throat
R2	MODIFY Arg1:T7 Arg2:E3	
T8	History 116 120	ESRD
#1	AnnotatorNotes T8	End-stage renal disease
T9	Disease_disorder 116 120	ESRD
E4	Disease_disorder:T9 
#2	AnnotatorNotes E4	End-stage renal disease
T10	Duration 168 176	15 years
E5	Duration:T10 
T11	Frequency 147 163	3 times per week
T12	Therapeutic_procedure 134 146	hemodialysis
E6	Therapeutic_procedure:T12 
R3	MODIFY Arg1:T11 Arg2:E6	
T13	Disease_disorder 178 191	hyperuricemia
E7	Disease_disorder:T13 
T14	Disease_disorder 196 200	gout
E8	Disease_disorder:T14 
T15	History 178 191	hyperuricemia
T16	History 196 200	gout
T17	Disease_disorder 235 247	dyslipidemia
E9	Disease_disorder:T17 
T18	Sign_symptom 249 261	hypertension
E10	Sign_symptom:T18 
T19	Disease_disorder 273 292	hyperparathyroidism
E11	Disease_disorder:T19 
T20	Disease_disorder 298 306	diabetes
E12	Disease_disorder:T20 
T21	Detailed_description 263 272	secondary
R4	MODIFY Arg1:T21 Arg2:E11	
T22	History 235 247	dyslipidemia
T23	History 249 261	hypertension
T24	History 273 292	hyperparathyroidism
T25	History 298 306	diabetes
T26	Diagnostic_procedure 312 320	hemogram
E13	Diagnostic_procedure:T26 
T27	Medication 639 650	antibiotics
E14	Medication:T27 
T28	Detailed_description 624 638	Broad-spectrum
R5	MODIFY Arg1:T28 Arg2:E14	
T29	Medication 656 668	piperacillin
E15	Medication:T29 
T30	Medication 677 687	tazobactam
E16	Medication:T30 
T31	Administration 696 700	i.v.
R6	MODIFY Arg1:T31 Arg2:E16	
T32	Dosage 688 695	0.25 gm
R7	MODIFY Arg1:T32 Arg2:E16	
T33	Dosage 669 672	2 g
R8	MODIFY Arg1:T33 Arg2:E15	
R9	SUB_PROCEDURE Arg1:E15 Arg2:E14	
R10	SUB_PROCEDURE Arg1:E16 Arg2:E14	
T34	Diagnostic_procedure 1927 1946	Chromosome analysis
E17	Diagnostic_procedure:T34 
T35	Biological_structure 1950 1961	bone marrow
R11	MODIFY Arg1:T35 Arg2:E17	
T36	Lab_value 1966 1982	normal karyotype
R12	MODIFY Arg1:T36 Arg2:E17	
T37	History 1996 2045	denied history of radiation or chemicals exposure
T38	Medication 2062 2072	febuxostat
E18	Medication:T38 
A1	POLARITY E18 NEG
T39	Duration 2077 2084	17 days
E19	Duration:T39 
T40	Clinical_event 2233 2242	discharge
E20	Clinical_event:T40 
T41	Diagnostic_procedure 2248 2251	WBC
E21	Diagnostic_procedure:T41 
T42	Diagnostic_procedure 2256 2274	differential count
E22	Diagnostic_procedure:T42 
T43	Lab_value 2290 2296	normal
R13	MODIFY Arg1:T43 Arg2:E22	
R14	MODIFY Arg1:T43 Arg2:E21	
T44	Clinical_event 2304 2313	follow-up
E23	Clinical_event:T44 
T45	Medication 1060 1070	febuxostat
E24	Medication:T45 
T46	Diagnostic_procedure 332 354	white blood cell count
E25	Diagnostic_procedure:T46 
T47	Diagnostic_procedure 356 359	WBC
E26	Diagnostic_procedure:T47 
R15	IDENTICAL Arg1:E26 Arg2:E25	
R16	SUB_PROCEDURE Arg1:E25 Arg2:E13	
T48	Lab_value 364 370	700/μL
R17	MODIFY Arg1:T48 Arg2:E25	
T49	Diagnostic_procedure 380 391	neutrophils
E27	Diagnostic_procedure:T49 
T50	Diagnostic_procedure 397 408	lymphocytes
E28	Diagnostic_procedure:T50 
T51	Diagnostic_procedure 416 425	monocytes
E29	Diagnostic_procedure:T51 
T52	Diagnostic_procedure 427 437	hemoglobin
E30	Diagnostic_procedure:T52 
T53	Diagnostic_procedure 453 467	platelet count
E31	Diagnostic_procedure:T53 
T54	Lab_value 469 479	131,000/μL
R18	MODIFY Arg1:T54 Arg2:E31	
T55	Lab_value 438 447	11.1 g/dL
R19	MODIFY Arg1:T55 Arg2:E30	
T56	Lab_value 413 415	2%
R20	MODIFY Arg1:T56 Arg2:E29	
T57	Lab_value 393 396	94%
R21	MODIFY Arg1:T57 Arg2:E28	
T58	Lab_value 377 379	2%
R22	MODIFY Arg1:T58 Arg2:E27	
R23	SUB_PROCEDURE Arg1:E27 Arg2:E13	
R24	SUB_PROCEDURE Arg1:E28 Arg2:E13	
R25	SUB_PROCEDURE Arg1:E29 Arg2:E13	
R26	SUB_PROCEDURE Arg1:E30 Arg2:E13	
R27	SUB_PROCEDURE Arg1:E31 Arg2:E13	
T59	Sign_symptom 513 524	neutropenia
E32	Sign_symptom:T59 
A2	POLARITY E32 UNCERTAIN
T60	Detailed_description 505 512	febrile
R28	MODIFY Arg1:T60 Arg2:E32	
T61	Detailed_description 529 534	acute
T62	Disease_disorder 535 546	pharyngitis
E33	Disease_disorder:T62 
R29	MODIFY Arg1:T61 Arg2:E33	
T63	Clinical_event 556 564	admitted
E34	Clinical_event:T63 
T64	Nonbiological_location 572 588	hematologic ward
R30	MODIFY Arg1:T64 Arg2:E34	
T65	Dosage 701 704	q8h
#3	AnnotatorNotes T65	every 8 hours
R31	MODIFY Arg1:T65 Arg2:E16	
T66	Sign_symptom 735 749	infection sign
E35	Sign_symptom:T66 
A3	TREND E35 DEC
T67	Medication 819 828	glipizide
E36	Medication:T67 
T68	Medication 839 850	saxagliptin
E37	Medication:T68 
T69	Medication 862 873	fenofibrate
E38	Medication:T69 
T70	Medication 885 903	aluminum hydroxide
E39	Medication:T70 
T71	Medication 916 926	folic acid
E40	Medication:T71 
T72	Medication 936 953	calcium carbonate
E41	Medication:T72 
T73	Medication 971 981	febuxostat
E42	Medication:T73 
T74	Duration 1110 1126	more than 1 year
E43	Duration:T74 
T75	Medication 1019 1031	epoetin-beta
E44	Medication:T75 
T76	Dosage 1032 1039	2000 iu
T77	Administration 1040 1044	i.v.
T78	Dosage 1044 1047	tiw
#4	AnnotatorNotes T78	three times a week
R32	MODIFY Arg1:T78 Arg2:E44	
R33	MODIFY Arg1:T76 Arg2:E44	
R34	MODIFY Arg1:T77 Arg2:E44	
T79	Dosage 851 860	2.5 mg qd
T80	Dosage 829 837	5 mg tid
R35	MODIFY Arg1:T80 Arg2:E36	
R36	MODIFY Arg1:T79 Arg2:E37	
T81	Dosage 874 883	600 mg qd
R37	MODIFY Arg1:T81 Arg2:E38	
T82	Dosage 904 914	324 mg tid
R38	MODIFY Arg1:T82 Arg2:E39	
T83	Dosage 927 934	5 mg qd
T84	Dosage 954 965	1000 mg tid
T85	Dosage 982 990	40 mg qd
R39	MODIFY Arg1:T85 Arg2:E42	
R40	MODIFY Arg1:T84 Arg2:E41	
R41	MODIFY Arg1:T83 Arg2:E40	
T86	Medication 1128 1138	Febuxostat
E45	Medication:T86 
T87	Date 1156 1172	2½ months before
E46	Date:T87 
T88	Medication 1225 1236	allopurinol
E47	Medication:T88 
T89	Dosage 1237 1245	50 mg qd
R42	MODIFY Arg1:T89 Arg2:E47	
T90	Date 1247 1263	Two weeks before
E48	Date:T90 
T91	Diagnostic_procedure 1293 1308	laboratory test
E49	Diagnostic_procedure:T91 
T92	Diagnostic_procedure 1318 1321	WBC
E50	Diagnostic_procedure:T92 
R43	SUB_PROCEDURE Arg1:E50 Arg2:E49	
T93	Lab_value 1322 1329	6000/μL
R44	MODIFY Arg1:T93 Arg2:E50	
T94	Diagnostic_procedure 1340 1349	uric acid
E51	Diagnostic_procedure:T94 
T95	Detailed_description 1334 1339	serum
R45	MODIFY Arg1:T95 Arg2:E51	
T96	Lab_value 1356 1365	9.8 mg/dL
R46	MODIFY Arg1:T96 Arg2:E51	
T97	Medication 1367 1377	Febuxostat
E52	Medication:T97 
A4	POLARITY E52 NEG
T98	Disease_disorder 1440 1455	agranulocytosis
E53	Disease_disorder:T98 
T99	Disease_disorder 1661 1671	infections
E54	Disease_disorder:T99 
A5	POLARITY E54 NEG
T100	Detailed_description 1632 1660	human immunodeficiency virus
T101	Detailed_description 1612 1627	cytomegalovirus
T102	Detailed_description 1592 1610	Epstein–Barr virus
R47	MODIFY Arg1:T100 Arg2:E54	
R48	MODIFY Arg1:T101 Arg2:E54	
R49	MODIFY Arg1:T102 Arg2:E54	
T103	Diagnostic_procedure 1673 1693	antinuclear antibody
E55	Diagnostic_procedure:T103 
T104	Diagnostic_procedure 1695 1698	ANA
E56	Diagnostic_procedure:T104 
R50	IDENTICAL Arg1:E56 Arg2:E55	
T105	Diagnostic_procedure 1704 1735	antiextractable nuclear antigen
E57	Diagnostic_procedure:T105 
T106	Diagnostic_procedure 1737 1745	anti-ENA
E58	Diagnostic_procedure:T106 
R51	IDENTICAL Arg1:E58 Arg2:E57	
T107	Lab_value 1757 1765	negative
R52	MODIFY Arg1:T107 Arg2:E57	
R53	MODIFY Arg1:T107 Arg2:E55	
T108	Diagnostic_procedure 1767 1790	Bone marrow examination
E59	Diagnostic_procedure:T108 
T109	Sign_symptom 1821 1833	hypocellular
E60	Sign_symptom:T109 
T110	Biological_structure 1834 1840	marrow
R54	MODIFY Arg1:T110 Arg2:E60	
T111	Diagnostic_procedure 1867 1884	myeloid component
E61	Diagnostic_procedure:T111 
T112	Lab_value 1855 1863	decrease
R55	MODIFY Arg1:T112 Arg2:E61	
T113	Sign_symptom 1916 1925	neoplasms
E62	Sign_symptom:T113 
A6	POLARITY E62 NEG
T114	Biological_structure 1904 1915	hematologic
R56	MODIFY Arg1:T114 Arg2:E62	
T115	Sign_symptom 2090 2101	neutropenia
E63	Sign_symptom:T115 
A7	TREND E63 DEC
T116	Diagnostic_procedure 2126 2129	WBC
E64	Diagnostic_procedure:T116 
T117	Diagnostic_procedure 2143 2153	neutrophil
E65	Diagnostic_procedure:T117 
T118	Lab_value 2130 2137	2100/μL
R57	MODIFY Arg1:T118 Arg2:E64	
T119	Lab_value 2154 2157	66%
R58	MODIFY Arg1:T119 Arg2:E65	
T120	Medication 2172 2209	granulocyte colony-stimulating factor
E66	Medication:T120 
A8	POLARITY E66 NEG
R59	AFTER Arg1:E1 Arg2:E2	
*	OVERLAP E2 E3
R60	AFTER Arg1:E3 Arg2:E4	
*	OVERLAP E4 E6 E5 E7 E8 E9 E10 E11 E12
R61	BEFORE Arg1:E12 Arg2:E13	
*	OVERLAP E13 E32 E33
R62	BEFORE Arg1:E33 Arg2:E34	
*	OVERLAP E34 E14
R63	BEFORE Arg1:E14 Arg2:E35	
R64	AFTER Arg1:E35 Arg2:E36	
*	OVERLAP E36 E37 E38 E39 E40 E41 E42 E44 E24 E43
A9	POLARITY E24 NEG
R65	BEFORE Arg1:E43 Arg2:E45	
*	OVERLAP E45 E46 E47
R66	AFTER Arg1:E47 Arg2:E48	
*	OVERLAP E48 E49
R67	SUB_PROCEDURE Arg1:E51 Arg2:E49	
R68	BEFORE Arg1:E49 Arg2:E52	
*	OVERLAP E52 E53 E54 E55 E57 E59 E60 E61 E62 E17
R69	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19
R70	BEFORE Arg1:E19 Arg2:E63	
*	OVERLAP E63 E64 E65 E66
R71	BEFORE Arg1:E66 Arg2:E20	
R72	BEFORE Arg1:E20 Arg2:E21	
*	OVERLAP E21 E22 E23
